[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359714-105":59,"doc-detail-359714-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","trimethylamine-producing-microbe-bacillus-megaterium-kctc-3007-promotes-antitumor-immunity-in-endometrial-cancer-via-type-i-interferon-response-pathways","Trimethylamine-producing microbe Bacillus megaterium KCTC 3007 promotes antitumor immunity in endometrial cancer via type I interferon response pathways","","Endometrial cancer has limited therapeutic responses in metastatic or recurrent settings, and the contribution of endometrial microbiota to disease course remains unclear. This study integrates metatranscriptomics, transcriptomics, and targeted metabolomics from 60 endometrial cancer patients and 18 benign controls, validating microbial-metabolite links via co-culture and immune assays. Bacillus megaterium KCTC 3007 is associated with prolonged recurrence-free survival, elevates TMAO, activates type I interferon signaling, expands CD8+ T cells, and induces pyroptotic cancer cell death.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/trimethylamine-producing-microbe-bacillus-megaterium-kctc-3007-promotes-antitumor-immunity-in-endometrial-cancer-via-type-i-interferon-response-pathways/359714/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/trimethylamine-producing-microbe-bacillus-megaterium-kctc-3007-promotes-antitumor-immunity-in-endometrial-cancer-via-type-i-interferon-response-pathways/359714.png","ImageObject",300,407,{"name":92,"@type":93},"Riley West","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s main goal regarding endometrial cancer and the microbiome?","Question",{"text":112,"@type":113},"To clarify how endometrial microbiota contributes to endometrial cancer pathogenesis and prognosis, focusing on microbial-metabolite-host mechanisms that may enhance antitumor immunity.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were microbiota and host interactions analyzed in the research?",{"text":117,"@type":113},"The study combined metatranscriptomics, transcriptomics, and targeted metabolomics, using RNA sequencing for active tissue-resident microbiota and host gene expression, plus serum metabolomics. Findings were validated with in vitro co-culture experiments and live cell imaging.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does Bacillus megaterium KCTC 3007 play in antitumor immunity?",{"text":121,"@type":113},"It is identified as beneficial and linked to longer recurrence-free survival. It promotes type I interferon response pathways, increases interleukin and interferon signaling, expands CD8+ T cells, and enhances immune interactions with tumor cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359714,1790209904,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099523885074,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Min etal. Microbiome (2026) 14:122  \n[https://doi.org/10.1186/s40168-026-02373-1](https://doi.org/10.1186/s40168-026-02373-1)  \nMicrobiome  \n RESEARCH Open Access  \nTrimethylamine-producing microbe Bacillus   megaterium KCTC 3007 promotes antitumor immunity in endometrial cancer via type I interferon response pathways  \nKyungchan Min1,5†, Se Ik Kim2,3†, Minji Lee1†, Yunjae Kim1, Chanyeong Jeong1, Sujeong Kim1,6, Sang Jin Kim 1, Hyun Kim 1, Beomki Cho1, Yanghyun Joo1, Hansoo Park1,4* and Maria Lee2,3*  \nAbstract  \nBackground Endometrial cancer (ECa) is one of the most common gynecologic malignancies, with limited therapeutic responses in metastatic or recurrent cases. The bacterial microbiota has emerged as a key modulator of carcinogenesis and antitumor immunity. However, the role of endometrial microbiota in ECa pathogenesis and prognosis remains poorly understood.  \nMethods We performed comprehensive multi-omics analysis integrating metatranscriptomics, transcriptomics, and targeted metabolomics from 60 ECa and 18 benign patients. RNA sequencing enabled simultaneous profiling of active tissue-resident microbiota and host gene expression. Serum metabolomics was conducted on all patients. Identified microbial-metabolite associations were validated through in vitro co-culture experiments using peripheral blood mononuclear cells (PBMCs), cancer cell lines, RNA sequencing, and live cell imaging.  \nResults ECa patients exhibited significantly altered microbial diversity and composition compared to benign controls. Through integrated multi-omics analysis, we identified Bacillus megaterium (BM) KCTC 3007 as a beneficial microbe associated with prolonged recurrence-free survival. In an exploratory analysis of ECa subtypes, Cupriavidus taiwanensis and Marinomonas primoryensis showed potential links to poor prognosis, although these observations warrant caution due to the limited size of certain subgroups. Tissue BM abundance positively correlated with serum trimethylamine N-oxide (TMAO) levels, particularly in postmenopausal women. In vitro experiments demonstrated that BM KCTC 3007 enhanced antitumor immunity by promoting interleukin and type I interferon expression, expanding CD8 + T cell populations, and increasing immune cell-tumor cell interactions. RNA sequencing revealed activation of interferon alpha response and immune cell proliferation pathways, with IFNAR1 identified as a key upstream regulator. TMAO treatment recapitulated these immune-activating effects, enhancing CD8 + T cell responses and preferentially inducing pyroptotic cancer cell death.  \n†Kyungchan Min, Se Ik Kim, and Minji Lee equally contributed to the work.  \n*Correspondence: Hansoo Park [hspark27@gist.ac.kr](hspark27@gist.ac.kr)[ ](hspark27@gist.ac.kr)Maria Lee [marialeemd@gmail.com](marialeemd@gmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](","cbCaiiK6kCyWKkwi","https://ap.wps.com/l/cbCaiiK6kCyWKkwi","pdf",8686006,31,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Keywords\n# Introduction","[{\"question\":\"What is the study’s main goal regarding endometrial cancer and the microbiome?\",\"answer\":\"To clarify how endometrial microbiota contributes to endometrial cancer pathogenesis and prognosis, focusing on microbial-metabolite-host mechanisms that may enhance antitumor immunity.\"},{\"question\":\"How were microbiota and host interactions analyzed in the research?\",\"answer\":\"The study combined metatranscriptomics, transcriptomics, and targeted metabolomics, using RNA sequencing for active tissue-resident microbiota and host gene expression, plus serum metabolomics. Findings were validated with in vitro co-culture experiments and live cell imaging.\"},{\"question\":\"What role does Bacillus megaterium KCTC 3007 play in antitumor immunity?\",\"answer\":\"It is identified as beneficial and linked to longer recurrence-free survival. It promotes type I interferon response pathways, increases interleukin and interferon signaling, expands CD8+ T cells, and enhances immune interactions with tumor cells.\"}]","Trimethylamine-producing microbe Bacillus megaterium KCTC 3007 promotes antitumor immunity in endometrial cancer via type I interferon response pathways | PDF",1790137628,78,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb098bf1776f9e1a1f411ea9d93935c7.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b39ab72c9b2c0380fe036b211d28376d.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/945459fcc3611938de26c47249170b11.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/06a2258b01420db864c13af2e24be068.webp",980,1301]